Empa MAN 25

Therapeutic Class

: Oral Hypoglycemic Agent

Manufacturer

: PMI

Country of origin

: Myanmar

Packaging

: 3 x 10’s Tablets

Dosage

: As prescribed by the physicians

Chemical composition

: Each tablet contains Empagliflozin 25 mg

Indications

: Glycemic control in adults with type 2 diabetes (alongside diet/exercise), reduce cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, and reduce the risk of cardiovascular death and hospitalization in adults with heart failure